Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07553286 Cetylpyridinium Chloride Hydrate Periodontal Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07553286 clinical trial report covering Cetylpyridinium Chloride Hydrate, Phase 3, endpoints, sponsor, geography, readout timing and development white spac
Read →
Latest Hotspot
8 min read
CTR20261336 Indacaterol Acetate/Mometasone Furoate Asthma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20261336 clinical trial report covering Indacaterol Acetate/Mometasone Furoate, Phase 3, endpoints, sponsor, geography, readout timing and development whit
Read →
Latest Hotspot
8 min read
ChiCTR2600123580 Dexamethasone Sodium Phosphate Acute Ischemic Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
ChiCTR2600123580 clinical trial report covering Dexamethasone Sodium Phosphate, Phase 3, endpoints, sponsor, geography, readout timing and development white s
Read →
Latest Hotspot
8 min read
ChiCTR2600123594 Adebrelimab Non-squamous non-small cell lung cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
ChiCTR2600123594 clinical trial report covering Adebrelimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07554495 Filgotinib Maleate Polyarticular Juvenile Idiopathic Arthritis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07554495 clinical trial report covering Filgotinib Maleate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07553351 Human Growth Hormone (Shandong Kexing Bioproducts) Growth Disorders Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07553351 clinical trial report covering Human Growth Hormone (Shandong Kexing Bioproducts), Phase 3, endpoints, sponsor, geography, readout timing and deve
Read →
Latest Hotspot
8 min read
NCT07554339 Durvalumab KRAS G12C mutant Non-small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07554339 clinical trial report covering Durvalumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07556848 Bulumtatug fuvedotin Triple Negative Breast Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07556848 clinical trial report covering Bulumtatug fuvedotin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07556731 Ferrous Succinate Anemia, Iron-Deficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07556731 clinical trial report covering Ferrous Succinate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07555938 Cevostamab Multiple Myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07555938 clinical trial report covering Cevostamab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07557420 Ravulizumab-CWVZ Neuromyelitis Optica Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07557420 clinical trial report covering Ravulizumab-CWVZ, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07559877 Chlorhexidine gluconate Nasopharyngeal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07559877 clinical trial report covering Chlorhexidine gluconate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
<
1
<<
1305
1306
1307
1308
1309
>>
2135
>